EICHOR
● Completed
A Study to Evaluate the Safety and Efficacy of Bermekimab in Patients With Moderate to Severe Atopic Dermatitis
Condition: Atopic Dermatitis · Eczema · Sponsor: Janssen Research & Development, LLC
About this study
A Study to Evaluate the Safety and Efficacy of Bermekimab in Patients With Moderate to Severe Atopic Dermatitis
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (17)
| Beach Clinical Research Inc | Huntington Beach, California, United States | — |
| Florida Academic Dermatology Centers | Coral Gables, Florida, United States | — |
| Doral Medical Research | Doral, Florida, United States | — |
| Floridian Research Institute | Miami, Florida, United States | — |
| Florida International Medical Research | Miami, Florida, United States | — |
| Premier Research Associate, Inc | Miami, Florida, United States | — |
| CNS HealthCare | Orlando, Florida, United States | — |
| Avita Clinical Research | Tampa, Florida, United States | — |
| Forcare Clinical Research Inc | Tampa, Florida, United States | — |
| Advanced Medical Research | Sandy Springs, Georgia, United States | — |
| Dawes Fretzin Clinical Research Group | Indianapolis, Indiana, United States | — |
| Randall Dermatology & Cosmetic Surgery | West Lafayette, Indiana, United States | — |
+ 5 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04021862